KFGK
CRBU icon

Keystone Financial Group (Kentucky)’s Caribou Biosciences CRBU Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
80,825
+350
+0.4% +$692 0.01% 532
2026
Q1 		$153K Hold
80,475
– – 0.01% 495
2025
Q4 		$128K Buy
+80,475
New +$169K 0.01% 440
2025
Q3 		– Sell
-63,975
Closed -$80.6K – 437
2025
Q2 		$80.6K Buy
63,975
+7,575
+13% +$7.45K 0.01% 421
2025
Q1 		$51.5K Buy
56,400
+11,000
+24% +$14.3K 0.01% 391
2024
Q4 		$72.2K Buy
+45,400
New +$91.3K 0.01% 384

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s CRBU Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) increased its Caribou Biosciences (CRBU) stake by 0.43% in Q2 2026, buying an estimated $692 and bringing the position to 80,825 shares worth $142K. The position accounts for 0.01% of the portfolio, ranked #532.

Keystone Financial Group (Kentucky) first reported a position in CRBU in Q4 2024 and has held it in 6 quarters since. The position peaked at $153K in Q1 2026. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Keystone Financial Group (Kentucky) held 80,825 shares of Caribou Biosciences worth $142K as of Q2 2026.
  • Keystone Financial Group (Kentucky) bought 350 Caribou Biosciences shares in Q2 2026, an estimated $692.
  • Caribou Biosciences made up 0.01% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #532 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Caribou Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Keystone Financial Group (Kentucky)'s Caribou Biosciences position peaked at $153K in Q1 2026.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.